Johannes Kirchner
Overview
Explore the profile of Johannes Kirchner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wrobel J, Kirchner J, Friedrichs K, Gietzen T, Althoff J, Hasse C, et al.
Clin Res Cardiol
. 2025 Mar;
PMID: 40063122
Background: Transtricuspid cardiac implantable electronic devices (CIEDs) complicate the management of tricuspid regurgitation (TR). Transcatheter tricuspid valve annuloplasty (TTVA) offers a promising approach due to minimal interaction with leaflets and...
2.
Rudolph F, Narang A, Korber M, Friedrichs K, Kirchner J, Ivannikova M, et al.
JACC Adv
. 2025 Feb;
4(2):101523.
PMID: 40021274
Background: The GLIDE Score is an anatomical scoring system designed to predict moderate residual tricuspid regurgitation (TR) immediately following transcatheter tricuspid edge-to-edge repair (T-TEER). Objectives: The purpose of this study...
3.
Rudolph F, Deutsch M, Friedrichs K, Renner A, Scholtz W, Gercek M, et al.
Clin Res Cardiol
. 2025 Jan;
PMID: 39878853
Background: Impaired renal function can increase cardiac troponin levels due to reduced elimination, potentially affecting its diagnostic utility. Limited data exist on high-sensitivity cardiac troponin I (hs-cTnI) kinetics after cardiac...
4.
Kirchner J, Gercek M, Omran H, Friedrichs K, Rudolph F, Rossnagel T, et al.
Front Cardiovasc Med
. 2025 Jan;
11:1463978.
PMID: 39877017
Background: The tricuspid annular plane systolic excursion (TAPSE) assessed by echocardiography has failed in predicting outcomes in patients with severe tricuspid regurgitation (TR) undergoing transcatheter tricuspid valve intervention (TTVI). Considering...
5.
Bormann J, Rudolph F, Miller M, Waezsada S, Kirchner J, Bleiziffer S, et al.
Clin Res Cardiol
. 2025 Jan;
PMID: 39777542
No abstract available.
6.
Stolz L, Rudolph F, Stocker T, Ivannikova M, Doldi P, Kirchner J, et al.
Eur J Heart Fail
. 2024 Dec;
PMID: 39725554
No abstract available.
7.
Bormann J, Rudolph F, Miller M, Waezsada S, Kirchner J, Bleiziffer S, et al.
Clin Res Cardiol
. 2024 Dec;
PMID: 39661146
Background: Elevated levels of lipoprotein(a) (Lp[a]) have been recognized as substantial risk factors for cardiovascular disease and aortic stenosis (AS). However, the specific role of Lp(a) in promoting aortic valve...
8.
Rudolph F, Gercek M, Kirchner J, Ivannikova M, Friedrichs K, Rudolph T, et al.
Clin Res Cardiol
. 2024 Dec;
114(2):290.
PMID: 39652120
No abstract available.
9.
Gercek M, Ivannikova M, Gercek M, Morsdorf M, Kirchner J, Rudolph F, et al.
Hellenic J Cardiol
. 2024 Nov;
PMID: 39515582
Objective: Transcatheter mitral valve interventions (TMVI) have been proven to reduce symptom burden and improve outcomes in patients with severe mitral regurgitation (MR). However, the impact of right ventricular function...
10.
Gercek M, Ivannikova M, Goncharov A, Gercek M, Morsdorf M, Kirchner J, et al.
Clin Res Cardiol
. 2024 Oct;
114(2):261-271.
PMID: 39382705
Background: Transcatheter tricuspid valve intervention (TTVI) has shown promising results with persistent reduction of tricuspid regurgitation (TR) and improvements in functional class and quality of life (QOL). Objectives: To analyze...